# Study of TH-302 Monotherapy as Second-line Treatment in Advanced Biliary Tract Cancer

> **NCT02433639** · PHASE2 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 24 (actual)

## Conditions studied

- Biliary Tract Cancer

## Interventions

- **DRUG:** TH-302 monotherapy

## Key facts

- **NCT ID:** NCT02433639
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2017-10
- **Final completion:** 2017-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02433639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02433639, "Study of TH-302 Monotherapy as Second-line Treatment in Advanced Biliary Tract Cancer". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT02433639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*